返回排名列表

ExlService Holdings, Inc. (EXLS)

被低估
TechnologyInformation Technology ServicesUnited States

基本面

76

价格

$34.38

市值

$5.25B

第一部分 · 这家公司值多少

概览

ExlService Holdings (EXL) is a data and artificial-intelligence company that runs analytics and business processes on behalf of other companies. It sells two broad things: data and AI-led solutions — analytics, data management and digital engineering embedded into a client's workflow — and digital operations, meaning technology-enabled managed services where EXL takes over a repetitive back-office process such as insurance claims handling, healthcare payment integrity or finance and accounting. The work is delivered mostly from low-cost locations: of more than 65,000 employees at the end of 2025, roughly 43,200 were in India, 13,400 in the Philippines, 4,100 in South Africa and only about 2,900 in the United States, across 50-plus offices on six continents. Clients are concentrated in insurance, healthcare and life sciences, banking and capital markets; the company served approximately 590 clients in 2025.

盈利方式

EXL sells services under master services agreements supplemented by individual statements of work. The mix runs from project-based engagements, typically shorter than a year, to long-term digital operations contracts that usually run three to five years. Revenue therefore arrives partly as recurring fees for running a process and partly as project fees for analytics and engineering work that must be re-won. There is no product licence and no hardware: revenue is essentially people and technology billed to the client, which is why employee costs and wage inflation sit at the centre of the margin story. In 2025 revenue was $2.09 billion, up 13.6% from $1.84 billion in 2024.

分部营收

Insurance34%

Analytics and managed operations for property and casualty and life insurers: underwriting support, claims handling, subrogation and actuarial analytics. Revenue was $710.6 million in 2025, up 8.3% year on year — the largest segment but the slowest grower.

Healthcare and Life Sciences25.5%

Services for health payers, providers and pharmaceutical companies — payment integrity, care management analytics and commercial analytics for drugmakers. Revenue was $532.5 million in 2025, up 23.6%, the fastest-growing segment.

Banking, Capital Markets and Diversified Industries23.1%

Data, analytics and operations for banks, asset managers and non-financial corporates, including finance and accounting outsourcing and customer operations. Revenue was $482.4 million in 2025, up 13.0%.

International Growth Markets17.3%

Clients outside EXL's core United States base — the United Kingdom, Europe, Australia and other markets — served across the same industry offerings. Revenue was $362.2 million in 2025, up 11.6%.

护城河

转换成本 · 狭窄

Once EXL is running a client's claims queue or payment-integrity process under a three-to-five-year contract, the client has handed over trained staff, workflow knowledge and data pipelines; moving the work back in-house or to a rival is slow and disruptive, which is what keeps the long-term operations contracts sticky. That stickiness is real but narrow: EXL competes against much larger Indian and global IT-services firms on work that is ultimately labour arbitrage plus domain expertise, the contracts come up for renewal and reprice, and generative AI cuts both ways — it can raise the value EXL adds, or let a client do the same work with fewer outsourced people. The company's own filing warns that use of AI technology presents competitive, reputational and legal risks and may not be successful.

需求驱动因素

中度周期性

Two different demands sit inside one company. The digital operations contracts run three to five years and cover work a client cannot stop doing — claims still have to be paid, invoices still have to be processed — so that revenue holds up through a downturn, and a recession can even push more work offshore as clients hunt for cost savings. The analytics and AI projects behave differently: they are discretionary technology budget, often under a year, and they are the first line item a client can defer when spending is cut. EXL itself flags that demand depends on anticipating the latest technology and can be affected by selling cycles. The result is a business that is steadier than pure consulting but more exposed than a regulated utility, with the sector mix — insurers and health payers, both defensive buyers — cushioning the swing.

主要风险

  • Demand and keeping up with technology — The company states that its business depends on maintaining and growing client demand for its services and solutions, including by anticipating and incorporating the latest technology into its offerings; a significant reduction in that demand, a failure to respond to the evolving technological environment, or a change in how it delivers its services could materially affect results of operations.
  • The AI bet may not work — EXL discloses that the use of AI technology presents competitive, reputational and legal risks and that its use of AI technology may not be successful. It notes that the domestic and international legal and regulatory landscape around AI is rapidly evolving and uncertain, including on intellectual property, cybersecurity, and privacy and data protection.
  • Selling cycles and contract terms — The company warns that client demand may be impacted by the selling cycle and by the terms of its client contracts, including for its AI-related offerings — a reminder that signed work can be slow to convert into revenue and that contract terms sit with the buyer.
  • Hiring and retaining people — EXL states that it may fail to attract and retain enough sufficiently trained employees to support its operations, or professionals with sufficient leadership capabilities. With more than 65,000 employees, the workforce is the product being sold.
  • Wage increases squeeze the margin — The filing states that employee wage increases may prevent the company from sustaining its competitive advantage and may reduce its profit margin. Because the model rests on delivering from lower-cost locations, wage inflation in India and the Philippines erodes the gap the client is paying for.
  • Taxes, repatriation and cross-border regulation — The company warns that its financial condition could be negatively affected if governments in the countries where it operates introduce unfavourable tax legislation, including legal restrictions on repatriating earnings, and that its global operations subject it to numerous legal and regulatory requirements, including accreditation or licensing standards governing its business.

客户集中度

主要客户占营收的34%

The 10-K discloses that the top ten clients accounted for 34.0% of revenues in 2025, the top five for 23.9% and the top three for 17.8%, with no single client representing more than 10% of total revenues. The company served approximately 590 clients, each with annual revenue above $50,000. So the tail is long and no one customer can sink the year, but a third of the business still sits with ten relationships — losing or repricing one of them is felt.

看多理由

Buyers argue that EXL sits on the right side of the AI shift rather than in front of it: it already holds the client's data and runs the workflow, so the tools that automate that work are tools EXL can sell back into an account it controls. They point to 2025 revenue of $2.09 billion, up 13.6%, with adjusted diluted earnings per share up 18.0% to $1.95, and to healthcare and life sciences growing 23.6% — evidence, they say, that the mix is tilting toward the faster, higher-value end rather than toward commodity back-office. They add that no client exceeds 10% of revenue, that the long-term operations contracts renew rather than have to be re-won each year, and that management guided 2026 revenue to $2.275–2.315 billion, 9–11% growth, while authorising a $500 million buyback over two years.

看空理由

Sellers fear that the same technology feeding the growth story eventually eats the revenue line. The company bills for people — over 65,000 of them, some 43,200 in India — and if generative AI does what its promoters claim, the client needs fewer of those people for the same outcome, which shows up as price pressure at renewal rather than as lost logos. EXL's own filing concedes that its use of AI technology presents competitive, reputational and legal risks and may not be successful, and that employee wage increases may prevent it from sustaining its competitive advantage and may reduce its profit margin — the pincer sellers point to: costs rising in India while pricing falls. They also note that the largest segment, insurance at 34.0% of 2025 revenue, grew only 8.3%, slower than the group; that the analytics work is discretionary budget with long selling cycles the company itself flags; and that the delivery model concentrates operational, tax and repatriation exposure in a handful of emerging-market jurisdictions.

Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users

P/E: 12.5Score: 67Market cap: $27.09B

Listed among EXL's large global competitors, Cognizant bids for the same insurance, banking and healthcare-payer contracts covering claims, policy administration and analytics work.

Genpact LimitedG

Named by EXL in its own 10-K, Genpact is the closest like-for-like rival: both sell offshore-delivered digital operations plus data and AI services to insurers, banks and healthcare payers from the same India-centric delivery base.

Capgemini SE (owner of WNS since October 2025)CAP

Capgemini is named as a competitor in EXL's 10-K and, having absorbed WNS in October 2025, it now also owns EXL's historic head-to-head rival in insurance and banking process outsourcing.

Accenture plcACN

Named in EXL's 10-K, Accenture chases the same corporate budgets for operations outsourcing and AI-led transformation, usually entering through consulting and then taking over the running of the process.

Cotiviti, Inc.Not tracked

Named by EXL as a niche competitor, Cotiviti sells payment integrity and clinical analytics to the same US health insurers that buy EXL's healthcare offering; it is privately held by Veritas Capital and KKR.

Infosys LimitedINFY

Named in EXL's 10-K, Infosys competes through Infosys BPM for the same outsourced finance, insurance and customer-operations contracts, bundling them with its IT services relationships.

资产负债表与流动性

营收

$2.16B

最近12个月(截至2026/3/31)

净利润

$252M

最近12个月(截至2026/3/31)

自由现金流

$298M

股东权益合计

$913M

负债合计

$790M

流动比率

2.66

利息覆盖率

18.78

债务/EBITDA

1.40

每股收益

营收与净利润

自由现金流

收入构成

历史财务表

利润率变化

债务变化

债务负担有多重

增长一览表

增长 — 营业收入

公允价值估算

一般情形被低估

公允价值

$52.72

当前价格

$34.38

安全边际

+34.8%

公允价值区间

$34.27 - $71.17

所用估值方法之间的离散区间,并非经过统计校准的置信区间。

估算方法

分析师目标价:$44.63
现金流折现法(DCF):$96.45
市盈率法(P/E):$22.17
格雷厄姆成长公式:$79.75
盈利能力价值(EPV):$18.48
合理市净率(P/B):$22.22
股息折现模型(戈登模型):数据不足,无法计算
P/FFO(运营资金):$32.49
周期中段收益:$39.67
市销率法(P/S):$74.72
分析师共识:强力买入 (15B / 1H / 0S)
最近财报超预期:+5.81%

估值指标

市盈率(P/E)

21.90

ROE

27.5%

市净率(P/B)

6.74

P/FCF

17.71

毛利率

38.5%

ROIC

18.8%

盈利能力雷达图

价值创造(经济护城河)

ROIC

18.8%

WACC

8.7%

ROIC − WACC

+10.1 pp

ROIC 超过资本成本:公司正在为股东创造价值。

基本面分析标准

通过(23)

  • EPS shows upward trend
  • EPS CAGR 6.89%
  • Price CAGR 13.19%
  • ROIC 18.8%
  • Gross Margin 38.5%
  • P/FCF 17.71
  • Debt/Equity ratio
  • Operating Margin 15.2%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 28.5%
  • Revenue Growth 5Y 16.9%
  • Analyst Consensus 94% Buy
  • Earnings Surprise avg 4.7%
  • PEG Ratio 0.86
  • Earnings Quality (OCF/NI) 1.39
  • Share Dilution -0.5%
  • Net Margin Trend 11.7% vs 11.4%
  • Piotroski F-Score 7/9

未通过(4)

  • P/B Ratio 6.74
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)

不可用(1)

  • Dividend Payout NaN%

Piotroski F-评分

7/9

财务状况强健

score
criteria

盈利质量

1.39

高质量:盈利有现金流支撑

股权稀释

-0.5%

正在回购股份,对股东友好

机构持股

公司治理

管理团队

姓名职位年龄
Mr. Rohit KapoorCo-Founder, Chairman & CEO60
Mr. Vikas BhallaPresident and Head of AI Services & Operations53
Mr. Vivek JetleyPresident and Head of Insurance, Healthcare & Life Sciences50
Mr. Maurizio Nicolelli CPAExecutive VP & CFO57
Mr. Narasimha KiniExecutive Vice President of Banking & Capital Markets and Diversified Industries56
Ms. Bhavna Newle ChopraSenior Vice President in Operations Management-
Mr. Baljinder SinghExecutive VP, Global Chief Information Officer & Head of Enterprise Digital Transformation52
Mr. Andrew ThutHead of Investor Relations & Capital Markets-
Mr. Ajay Ayyappan J.D.Executive VP, General Counsel & Corporate Secretary47
Mr. Joel KatzSenior VP and Chief Compliance & Ethics Officer-

审计风险

1

董事会风险

5

薪酬风险

1

股东权利风险

4

第二部分 · 价格与买入时机

这一部分不判断公司是否值得拥有:它帮助你在基本面说服你之后,选择何时买入。包含:技术分析、潜力、历史回撤、Gamma 敞口。

文件

  • 年度报告(10-K)

    对公司业务、财务业绩和风险的年度概述。

    提交日期:2026-02-24

    查看文件
  • 季度报告(10-Q)

    最近三个月财务表现的最新情况。

    提交日期:2026-07-28

    查看文件
  • 临时报告(8-K)

    关于重大事件(如管理层变动或重要公告)的通知。

    提交日期:2026-09-02

    查看文件

via SEC EDGAR

损益历史

via SEC EDGAR

Latest News

Recent headlines for EXLS, sourced from Markets Gazette.

  • 3/11/2026NEGATIVE
    EXL Stock Down 41% Year Over Year as One Investor Reveals $68 Million Exit

    ExlService Holdings Inc. (EXLS) has experienced a significant 41% decline in its stock value over the past year. This downturn is highlighted by a substantial $68 million exit by a key investor, signaling a potential loss of confidence or a strategic shift. The company, which provides digital operations and analytics solutions to the insurance, healthcare, and life sciences sectors, faces increased scrutiny from the market. Investors are likely reassessing the company's growth prospects and competitive positioning in light of this exit and the substantial share price depreciation.

  • 2/25/2026NEUTRAL
    ExlService (EXLS) Q4 2025 Earnings Call Transcript

    Investors in ExlService (EXLS) are currently awaiting the release of the transcript from the company's fourth-quarter 2025 earnings call. While the event has been announced, specific details regarding key financial metrics such as revenue, earnings per share, and future guidance are not yet available. The market will closely scrutinize this information to assess the company's performance during the period and its growth prospects. The absence of concrete data currently prevents a directional judgment on the potential impact these results might have on the stock. The reaction of EXLS shares will entirely depend on the strength of the numbers presented and the future projections outlined by management.

via Markets Gazette